{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-15",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "San Diego",
      "state": "CA",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Devices",
      "event_id": "72651",
      "recalling_firm": "Ameditech Inc",
      "address_1": "9940 Mesa Rim Rd",
      "address_2": "N/A",
      "postal_code": "92121-2910",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide Distribution.",
      "recall_number": "Z-0506-2016",
      "product_description": "iCup DX 8 Panel w/Adulterant, Item No. I-DXA-187-016",
      "product_quantity": "8,290 units",
      "reason_for_recall": "Ameditechs Drugs of Abuse Tests listed above have shown reduced reactivity for up to two (2) of the nineteen (19) Benzodiazepine (BZO) compounds for which specificity information is provided in the product insert. The particular BZO compounds for which there may be reduced reactivity are Clonazepam and Chlordiazepoxide.",
      "recall_initiation_date": "20151116",
      "center_classification_date": "20151224",
      "termination_date": "20161109",
      "report_date": "20151230",
      "code_info": "141971  142195  142397  142674  142997  144209  144463  150018  150883  151525  151526  152180  152741  153045  153150  153151  153211  153376  153650"
    }
  ]
}